racemetirosine has been researched along with Carcinoma, Large Cell in 1 studies
alpha-Methyltyrosine: An inhibitor of the enzyme TYROSINE 3-MONOOXYGENASE, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with PHEOCHROMOCYTOMA. (Martindale, The Extra Pharmacopoeia, 30th ed)
Carcinoma, Large Cell: A tumor of undifferentiated (anaplastic) cells of large size. It is usually bronchogenic. (From Dorland, 27th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaira, K | 1 |
| Oriuchi, N | 1 |
| Shimizu, K | 1 |
| Ishikita, T | 1 |
| Higuchi, T | 1 |
| Imai, H | 1 |
| Yanagitani, N | 1 |
| Sunaga, N | 1 |
| Hisada, T | 1 |
| Ishizuka, T | 1 |
| Kanai, Y | 1 |
| Endou, H | 1 |
| Nakajima, T | 1 |
| Endo, K | 1 |
| Mori, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Correlation of Angiogenesis With 18F-FMT and 18F-FDG Uptake in Non-Small Cell Lung Cancer[NCT00671242] | 0 participants | Observational | Completed | ||||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 other study available for racemetirosine and Carcinoma, Large Cell
| Article | Year |
|---|---|
Correlation of angiogenesis with 18F-FMT and 18F-FDG uptake in non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; alpha-Methyltyrosine; Antigens, CD34; Carcinoma, Lar | 2009 |